Avalyn Pharma

Avalyn pharma email format

Verified email-pattern data for Avalyn Pharma is currently limited. You can still use the company insights and contact sections below.
Avalyn is reimagining the future of pulmonary fibrosis treatment, with a pipeline of new inhaled formulations of approved medicines. Unlike currently available oral therapies, our inhaled approach allows us to tackle the underlying pathophysiology of pulmonary fibrosis at its source by safely delivering treatments directly into the lungs – improving tolerability by decreasing systemic exposure and improving efficacy by increasing lung exposure. Our lead candidate, AP01, is an optimized inhaled formulation of pirfenidone, currently being studied for progressive pulmonary fibrosis in the Phase 2b MIST study. In addition, we completed two Phase 1 studies for AP02, an optimized inhaled formulation of nintedanib. At Avalyn, we are driven by our mission to empower lives through breakthrough inhaled therapies for interstitial lung diseases, turning breathlessness into hope.

Company Details

Employees
50
Address
Cambridge, Massachusetts 02142, Us
Industry
Biotechnology Research
Keywords
jobs.
HQ
Cambridge, Massachusetts
Looking for a particular Avalyn Pharma employee's phone or email?

Avalyn Pharma Questions

Explore related pages

Related company profiles:

Top Avalyn Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant